Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancers

S E Hiscox1, M B Hallett, M C Puntis

  • 1Department of Surgery, University of Wales College of Medicine, Heath Park, Cardiff, U.K.

Cancer Investigation
|January 1, 1997
PubMed

Insights

Colorectal cancer tissues overexpress the c-met receptor, a key protein in cell movement. This suggests increased sensitivity to hepatocyte growth factor/scatter factor (HGF/SF), potentially enhancing cancer metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The c-met proto-oncogene product is a receptor tyrosine kinase.
  • It mediates the effects of hepatocyte growth factor/scatter factor (HGF/SF).
  • HGF/SF is crucial for tumor cell motility and invasion, key factors in cancer metastasis.

Purpose of the Study:

  • To investigate the expression of the c-met receptor and HGF/SF in colorectal cancer tissues.
  • To assess the functional activity of c-met in colorectal cancer cells.
  • To explore the correlation between c-met expression and clinicopathological features.

Main Methods:

  • Studied c-met and HGF/SF expression at both mRNA and protein levels in colorectal cancer tissues.
  • Utilized viable tumor cell extraction and stimulation assays.
  • Analyzed expression data against tumor stage and differentiation grade.

Main Results:

  • All tumors showed overexpression of c-met mRNA compared to normal tissues.
  • 75% of colorectal cancer tissues displayed up-regulated c-met protein.
  • No HGF/SF mRNA or protein was detected in either tumor or normal tissues.
  • Stimulated tumor cells exhibited increased motility in response to HGF/SF, confirming functional c-met activity.
  • No correlation was found between c-met expression and tumor stage or differentiation.

Conclusions:

  • Colorectal cancers frequently overexpress the c-met receptor.
  • This overexpression may lead to heightened sensitivity to HGF/SF.
  • Such sensitivity could potentially enhance the metastatic potential of colorectal cancer cells.